How to buy Guardant Health stock (GH)

Guardant Health is a diagnostics & research business based in the US. Guardant Health shares (GH) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $31.13 – a decrease of 10.44% over the previous week. Guardant Health employs 1,768 staff and has a trailing 12-month revenue of around $692.3 million.

Our top picks for where to buy Guardant Health stock

Buy Guardant Health stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Guardant Health stock price (NASDAQ: GH)

Use our graph to track the performance of GH stocks over time.

Guardant Health shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$31.13
52-week range	$15.81 - $38.53
50-day moving average more info button	$28.20
200-day moving average more info button	$25.64
Wall St. target price	$43.20
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-4.28

Is it a good time to buy Guardant Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Guardant Health price performance over time

Historical closes compared with the close of $32.36 from 2024-12-18

1 week (2024-12-13)	-6.90%
1 month (2024-11-21)	4.45%
3 months (2024-09-20)	28.98%
6 months (2024-06-20)	9.47%

1 year (2023-12-20)	28.31%
2 years (2022-12-20)	7.87%
3 years (2021-12-20)	99.67
5 years (2019-12-20)	82.78

Guardant Health financials

Revenue TTM	$692.3 million
Gross profit TTM	$293.2 million
Return on assets TTM	-16.08%
Return on equity TTM	-609.28%
Profit margin	-74.02%
Book value	$-0.49
Market Capitalization more info button	$4 billion

TTM: trailing 12 months

Guardant Health share dividends

We're not expecting Guardant Health to pay a dividend over the next 12 months.

Guardant Health share price volatility

Over the last 12 months, Guardant Health's shares have ranged in value from as little as $15.81 up to $38.53. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Guardant Health's is 1.106. This would suggest that Guardant Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Guardant Health overview

Guardant Health, Inc. , a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research.

Frequently asked questions

null
What percentage of Guardant Health is owned by insiders or institutions?
Currently 4.566% of Guardant Health shares are held by insiders and 105.637% by institutions. How many people work for Guardant Health?
Latest data suggests 1,768 work at Guardant Health. When does the fiscal year end for Guardant Health?
Guardant Health's fiscal year ends in December. Where is Guardant Health based?
Guardant Health's address is: 3100 Hanover Street, Palo Alto, CA, United States, 94304 What is Guardant Health's ISIN number?
Guardant Health's international securities identification number is: US40131M1099 What is Guardant Health's CUSIP number?
Guardant Health's Committee on Uniform Securities Identification Procedures number is: 40131M109